Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net (loss) income $ (6,737,962) $ 85,581,025
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization 37,987 86,535
Loss on disposal and abandonment of assets 100,270
Compounded interest on long term debt 41,624 143,114
Stock compensation expense 137,964 147,165
Change in fair value of financial instruments (140,485)
Loss on extinguishment of debt 4,265,434 1,314,102
Issued warrants in connection with Asset Sale 3,337,187
Value of stock issued to directors 10,500
Value of stock issued to employees 165,021 367,812
Value of stock issued to 401(k) plan for employer matching contributions 35,980
Changes in operating assets and liabilities:    
Accounts and other receivables (7,749) (14,821,403)
Inventory 1,470,078
Prepaid expenses and other assets 50,805 (65,632)
Accounts payable (154,811) (3,837,463)
Accrued and other liabilities (79,109) (3,719,024)
Deferred revenue (15,037) (2,315,037)
Net cash (used in) provided by operating activities (2,259,853) 67,658,744
Cash flows from investing activities:    
Maturities of available-for-sale securities 400,000
Net cash provided by investing activities 400,000
Cash flows from financing activities:    
Proceeds from issuance of common stock 200 54,119
Payment of debt-related costs (1,314,102)
Principal payments on notes payable (118,337) (59,498,721)
Net cash used in financing activities (118,137) (60,758,704)
Net (decrease) increase in cash, cash equivalents and restricted cash (1,977,990) 6,900,040
Cash, cash equivalents and restricted cash, beginning of period 2,795,006 6,540,578
Cash, cash equivalents and restricted cash, end of period $ 817,016 $ 13,440,618